Taking a half dose from a Wegovy pen: what the evidence says

Step 1, understand how the pen is built before assuming it can flex

Wegovy is supplied as a pre-filled, single-dose injection pen. Press the button and the device delivers the entire contents in one continuous movement. There is no dial, no click-count and no way to release a partial volume and re-cap for later. The mechanics are by design: consistent delivery protects both efficacy and safety.

The dose each pen contains corresponds to your current step in the titration schedule, 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg or 2.4 mg for the standard pen, rising to 7.2 mg with the newer single-dose format the MHRA approved in April 2026. Whichever pen you are holding, it holds exactly that amount. Stopping mid-injection does not split the dose predictably; it wastes medicine and delivers an unknown quantity.

If you pull the pen out early, you have no way of knowing how much was absorbed. The subcutaneous tissue also absorbs semaglutide over a slightly variable window depending on injection depth and site. In short, a self-attempted partial dose is not a half dose in any meaningful clinical sense.

Step 2, recognise what you are probably trying to solve

The most common reason people search for information on whether a Wegovy half dose is possible is nausea or another gastrointestinal side effect. That is understandable. Semaglutide's GI profile (nausea, loose stools, reduced appetite, occasional vomiting) tends to peak in the first week or two after a dose increase, then settle. The NHS semaglutide medicines page notes that these effects are generally temporary and most pronounced around the time your body is adjusting to a new level.

Other people ask because they feel the current dose is working well and want to stay there longer before moving up. That instinct is completely reasonable, and a prescriber can formally pause your titration. There is a difference between a deliberate, reviewed hold at your current dose and an improvised reduction achieved by fumbling with the pen.

A third group are asking about cost. Stretching a pen further does not actually reduce what you spend per pen; you still pay for the full device. The cost picture for Wegovy in the UK is worth reading properly rather than trying to engineer savings through under-dosing.

Step 3, what your prescriber can actually do

A prescriber has several legitimate levers. They can hold your titration at its current step for an additional month. They can advise on timing the injection, some people find injecting on a Friday evening means the worst of any nausea passes over the weekend. They can recommend eating habits that reduce GI impact: smaller meals, lower fat content, taking more time between bites. Your pen, meanwhile, stays in the fridge door until injection day, and that routine itself is worth keeping predictable.

What a prescriber cannot do for you is endorse a self-modified dosing approach that bypasses the device's calibration. The Wegovy SmPC on the eMC sets out the licensed dosing schedule in full, it does not include a half-dose option at any stage. Anything outside that schedule sits outside the product's evidence base.

If side effects feel unmanageable, contact your prescribing team directly. At nume, aftercare is available seven days a week, you do not have to wait for a scheduled review. Our prescribers can formally adjust your plan; the detail of all the Wegovy dose steps and what each one means clinically is worth reading before that conversation.

Step 4, a note on the click-counting approach circulating online

Some online forums describe counting the audible clicks during injection to estimate a partial volume. This is not a validated method. Click counts vary by device batch, injection angle and user technique. The idea that clicks correspond to a measurable dose fraction is not supported by Novo Nordisk's device engineering or by any published clinical guidance. Relying on it exposes you to underdosing or overdosing without any way to know which.

If you are unsure whether your current dose is appropriate, or you want a clinical opinion on pausing your titration, that question deserves a real answer from a prescriber who can review your full history. Check your eligibility and start a free consultation to speak with our clinical team.